Regulatory T cells in human ovarian cancer

Journal of Oncology

Volumn , Issue , 2012, Pages

  Peng, Dong Jun ^a   Liu, Rebecca ^a   Zou, Weiping ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; B7 ANTIGEN; BASILIXIMAB; CD134 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR8; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DACLIZUMAB; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE DERIVED CHEMOKINE; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; VASCULOTROPIN;

AUTOIMMUNE DISEASE; CANCER PROGNOSIS; CANCER SURVIVAL; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARY CANCER; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T CELL DEPLETION; TH3 CELL; THYMUS; TUMOR MICROENVIRONMENT;

EID: 84858240548     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/345164     Document Type: Review

References (81)

1. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010 CA Cancer Journal for Clinicians 2010 60 5 277 300
2. Zhang L., Conejo-Garcia J. R., Katsaros D., Gimotty P. A., Massobrio M., Regnani G., Makrigiannakis A., Gray H., Schlienger K., Liebman M. N., Rubin S. C., Coukos G., Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer New England Journal of Medicine 2003 348 3 203 213 (Pubitemid 36077915)
3. Sato E., Olson S. H., Ahn J., Bundy B., Nishikawa H., Qian F., Jungbluth A. A., Frosina D., Gnjatic S., Ambrosone C., Kepner J., Odunsi T., Ritter G., Lele S., Chen Y. -T., Ohtani H., Old L. J., Odunsi K., Intraepithelial CD8 + tumor-infiltrating lymphocytes and a high CD8 + /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 2005 102 51 18538 18543 (Pubitemid 43011261)
4. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nature Medicine 2004 10 9 942 949 (Pubitemid 39273735)
5. Curotto de Lafaille M. A., Lafaille J. J., Natural and adaptive Foxp3 + regulatory T cells: more of the same or a division of labor? Immunity 2009 30 5 626 635
6. Zou W., Regulatory T cells, tumour immunity and immunotherapy Nature Reviews Immunology 2006 6 4 295 307
7. Gershon R. K., Kondo K., Cell interactions in the induction of tolerance: the role of thymic lymphocytes Immunology 1970 18 5 723 737
8. Gershon R. K., Kondo K., Infectious immunological tolerance Immunology 1971 21 6 903 914
9. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL- 2 receptor -chains (CD25): breakdown of a single mechanism of self- tolerance causes various autoimmune diseases Journal of Immunology 1995 155 3 1151 1164
10. Hori S., Nomura T., Sakaguchi S., Control of regulatory T cell development by the transcription factor Foxp3 Science 2003 299 5609 1057 1061 (Pubitemid 36222930)
11. Shevach E. M., CD4 + CD25 + suppressor T cells: more questions than answers Nature Reviews Immunology 2002 2 6 389 400 (Pubitemid 37328746)
12. Sakaguchi S., Naturally arising Foxp3-expressing CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self Nature Immunology 2005 6 4 345 352 (Pubitemid 41716771)
13. Stephens L.A., Mottet C., Mason D., Human CD4 + CD25 + thymocytes and peripheral T cells have immune suppressive activity in vitro Eur J Immunol 2001 31 4 1247 1254
14. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., De Vries J. E., Roncarolo M. G., A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 1997 389 6652 737 742 (Pubitemid 27458961)
15. Smith T. R. F., Kumar V., Revival of CD8 + Treg-mediated suppression Trends in Immunology 2008 29 7 337 342
16. Jonuleit H., Schmitt E., The regulator T cell family: distinct subsets and their interrelations Journal of Immunology 2003 171 12 6323 6327 (Pubitemid 37532056)
17. Jones E., Dahm-Vicker M., Simon A. K., Green A., Powrie F., Cerundolo V., Gallimore A., Depletion of CD25 + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice Cancer Immunity 2002 2 1
18. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T., Nakayama E., Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor ) monoclonal antibody Cancer Research 1999 59 13 3128 3133 (Pubitemid 29316012)
19. Golgher D., Jones E., Powrie F., Elliott T., Gallimore A., Depletion of CD25 + regulatory cells uncovers immune responses to shared murine tumor rejection antigens European Journal of Immunology 2002 32 11 3267 3275 (Pubitemid 35414884)
20. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H., Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clinical Cancer Research 2003 9 12 4404 4408 (Pubitemid 37248397)
21. Woo E. Y., Chu C. S., Goletz T. J., Schlienger K., Yeh H., Coukos G., Rubin S. C., Kaiser L. R., June C. H., Regulatory CD4 + CD25 + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Research 2001 61 12 4766 4772 (Pubitemid 32691889)
22. Liyanage U. K., Moore T. T., Joo H. G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S., Linehan D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma Journal of Immunology 2002 169 5 2756 2761 (Pubitemid 34921025)
23. Ormandy L., Hillemann T., Wedemeyer H., Manns M. P., Greten T. F., Korangy F., Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Research 2005 65 6 2457 2464 (Pubitemid 40490158)
24. Schott A. K., Pries R., Wollenberg B., Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer International Journal of Molecular Medicine 2010 26 1 67 75
25. lvaro T., Lejeune M., Salvad M. T., Bosch R., Garca J. F., Jaén J., Banham A. H., Roncador G., Montalbn C., Piris M. A., Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells Clinical Cancer Research 2005 11 4 1467 1473 (Pubitemid 40315228)
26. Steitz J., Brck J., Lenz J., Knop J., Tting T., Depletion of CD25 + CD4 + T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon -induced, CD8 + T-cell-dependent immune defense of B16 melanoma Cancer Research 2001 61 24 8643 8646 (Pubitemid 34013869)
27. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., D'Ambrosio D., Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4 + CD25 + regulatory T cells Journal of Experimental Medicine 2001 194 6 847 853 (Pubitemid 32983019)
28. Wu M. T., Fang H., Hwang S. T., Cutting edge: CCR4 mediates antigen-primed T cell binding to activated dendritic cells Journal of Immunology 2001 167 9 4791 4795 (Pubitemid 33009704)
29. Tang H. L., Cyster J. G., Chemokine up-regulation and activated T cell attraction by maturing dendritic cells Science 1999 284 5415 819 822 (Pubitemid 29291350)
30. Haas J., Schopp L., Storch-Hagenlocher B., Fritzsching B., Jacobi C., Milkova L., Fritz B., Schwarz A., Suri-Payer E., Hensel M., Wildemann B., Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis Blood 2008 111 2 761 766
31. Ishida T., Ishii T., Inagaki A., Yano H., Komatsu H., Iida S., Inagaki H., Ueda R., Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege Cancer Research 2006 66 11 5716 5722 (Pubitemid 43927124)
32. Ménétrier-Caux C., Gobert M., Caux C., Differences in tumor regulatory T-cell localization and activation status impact patient outcome Cancer Research 2009 69 20 7895 7898
33. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., Fujii H., CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3 + regulatory T cells in gastric cancer International Journal of Cancer 2008 122 10 2286 2293 (Pubitemid 351542333)
34. Tan M. C. B., Goedegebuure P. S., Belt B. A., Flaherty B., Sankpal N., Gillanders W. E., Eberlein T. J., Hsieh C. S., Linehan D. C., Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer Journal of Immunology 2009 182 3 1746 1755
35. Kleinewietfeld M., Puentes F., Borsellino G., Battistini L., Rtzschke O., Falk K., CCR6 expression defines regulatory effector/memory-like cells within the CD25 + CD4 + T-cell subset Blood 2005 105 7 2877 2886 (Pubitemid 40446282)
36. Papiernik M., De Moraes M. L., Pontoux C., Vasseur F., Pénit C., Regulatory CD4 T cells: expression of IL-2R chain, resistance to clonal deletion and IL-2 dependency International Immunology 1998 10 4 371 378 (Pubitemid 28182093)
37. Penhale W. J., Irvine W. J., Inglis J. R., Farmer A., Thyroiditis in T cell depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells Clinical and Experimental Immunology 1976 25 1 6 16
38. Sakaguchi S., Miyara M., Costantino C. M., Hafler D. A., FOXP3 + regulatory T cells in the human immune system Nature Reviews Immunology 2010 10 7 490 500
39. Jordan M. S., Boesteanu A., Reed A. J., Petrone A. L., Holenbeck A. E., Lerman M. A., Naji A., Caton A. J., Thymic selection of CD4 + CD25 + regulatory T cells induced by an agonist self-peptide Nature Immunology 2001 2 4 301 306 (Pubitemid 33706340)
40. Zou W., Immunosuppressive networks in the tumour environment and their therapeutic relevance Nature Reviews Cancer 2005 5 4 263 274 (Pubitemid 40488632)
41. Jonuleit H., Schmitt E., Schuler G., Knop J., Enk A. H., Induction of interleukin 10-producing, nonproliferating CD4 + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells Journal of Experimental Medicine 2000 192 9 1213 1222
42. Dhodapkar M. V., Steinman R. M., Krasovsky J., Munz C., Bhardwaj N., Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells Journal of Experimental Medicine 2001 193 2 233 238 (Pubitemid 32524454)
43. Zoul W., Machelon V., Coulomb-L'Hermin A., Borvakz J., Nome F., Isaeva T., Wei S., Krzysieks R., Durand-Gasselin I., Gordon A., Pustilnik T., Curiel D. T., Galanaud P., Capron F., Emilie D., Curiel T. J., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells Nature Medicine 2001 7 12 1339 1346 (Pubitemid 34007939)
44. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., Curiel T., Lange A., Zou W., Plasmacytoid dendritic cells induce CD8 + regulatory T cells in human ovarian carcinoma Cancer Research 2005 65 12 5020 5026 (Pubitemid 40827308)
45. Ghiringhelli F., Puig P. E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L., Tumor cells convert immature myeloid dendritic cells into TGF- -secreting cells inducing CD4 + CD25 + regulatory T cell proliferation Journal of Experimental Medicine 2005 202 7 919 929 (Pubitemid 41396892)
46. Chen W., Jin W., Hardegen N., Lei K. -J., Li L., Marinos N., McGrady G., Wahl S. M., Conversion of peripheral CD4 + CD25 - naive T cells to CD4 + CD25 + regulatory T cells by TGF- induction of transcription factor Foxp3 Journal of Experimental Medicine 2003 198 12 1875 1886 (Pubitemid 38032120)
47. Shimizu J., Yamazaki S., Sakaguchi S., Induction of tumor immunity by removing CD25 + CD4 + T cells: a common basis between tumor immunity and autoimmunity Journal of Immunology 1999 163 10 5211 5218
48. Dannull J., Su Z., Rizzieri D., Yang B. K., Coleman D., Yancey D., Zhang A., Dahm P., Chao N., Gilboa E., Vieweg J., Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells Journal of Clinical Investigation 2005 115 12 3623 3633 (Pubitemid 43121851)
49. Vincenti F., Kirkman R., Light S., Bumgardner G., Pescovitz M., Halloran P., Neylan J., Wilkinson A., Ekberg H., Gaston R., Backman L., Burdick J., Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation New England Journal of Medicine 1998 338 3 161 165 (Pubitemid 28041863)
50. Nashan B., Moore R., Amlot P., Schmidt A.-G., Abeywickrama K., Soulillou J.-P., Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients The Lancet 1997 350 9086 1193 1198 (Pubitemid 127445091)
51. Rech A. J., Vonderheide R. H., Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells Annals of the New York Academy of Sciences 2009 1174 99 106
52. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T. W., Sakaguchi S., Immunologic self-tolerance maintained by CD25 + CD4 + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 Journal of Experimental Medicine 2000 192 2 303 310
53. Read S., Malmstrm V., Powrie F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 + CD4 + regulatory cells that control intestinal inflammation Journal of Experimental Medicine 2000 192 2 295 302 (Pubitemid 30470312)
54. Leach D. R., Krummel M. F., Allison J. P., Enhancement of antitumor immunity by CTLA-4 blockade Science 1996 271 5256 1734 1736 (Pubitemid 26102823)
55. Hodi F. S., Butler M., Oble D. A., Seiden M. V., Haluska F. G., Kruse A., MacRae S., Nelson M., Canning C., Lowy I., Korman A., Lautz D., Russell S., Jaklitsch M. T., Ramaiya N., Chen T. C., Neuberg D., Allison J. P., Mihm M. C., Dranoff G., Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients Proceedings of the National Academy of Sciences of the United States of America 2008 105 8 3005 3010 (Pubitemid 351723658)
56. Phan G. Q., Yang J. C., Sherry R. M., Hwu P., Topalian S. L., Schwartzentruber D. J., Restifo N. P., Haworth L. R., Seipp C. A., Freezer L. J., Morton K. E., Mavroukakis S. A., Duray P. H., Steinberg S. M., Allison J. P., Davis T. A., Rosenberg S. A., Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8372 8377 (Pubitemid 36842552)
57. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S., Stimulation of CD25 + CD4 + regulatory T cells through GITR breaks immunological self-tolerance Nature Immunology 2002 3 2 135 142 (Pubitemid 34141443)
58. Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., Shimizu J., Nomura T., Chiba T., Sakaguchi S., Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells Journal of Experimental Medicine 2005 202 7 885 891 (Pubitemid 41396888)
59. Turk M. J., Guevara-Patio J. A., Rizzuto G. A., Engelhorn M. E., Houghton A. N., Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells Journal of Experimental Medicine 2004 200 6 771 782 (Pubitemid 39299463)
60. Valzasina B., Guiducci C., Dislich H., Killeen N., Weinberg A. D., Colombo M. P., Triggering of OX40 (CD134) on CD4 + CD25 + T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR Blood 2005 105 7 2845 2851 (Pubitemid 40446278)
61. Takeda I., Ine S., Killeen N., Ndhlovu L. C., Murata K., Satomi S., Sugamura K., Ishii N., Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells Journal of Immunology 2004 172 6 3580 3589 (Pubitemid 38337939)
62. Lutsiak M. E. C., Semnani R. T., De Pascalis R., Kashmiri S. V. S., Schlom J., Sabzevari H., Inhibition of CD4 + 25 + T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide Blood 2005 105 7 2862 2868 (Pubitemid 40446280)
63. Turk M. J., Guevara-Patio J. A., Rizzuto G. A., Engelhorn M. E., Houghton A. N., Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells Journal of Experimental Medicine 2004 200 6 771 782 (Pubitemid 39299463)
64. Kawai M., Kitade H., Mathieu C., Waer M., Pirenne J., Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo Transplantation 2005 79 9 1073 1077 (Pubitemid 40664000)
65. Shibutani S., Inoue F., Aramaki O., Akiyama Y., Matsumoto K., Shimazu M., Kitajima M., Ikeda Y., Shirasugi N., Niimi M., Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen Transplantation 2005 79 8 904 913 (Pubitemid 40586862)
66. Mailloux A. W., Young M. R. I., Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression Critical Reviews in Immunology 2010 30 5 435 447
67. Zou L., Barnett B., Safah H., LaRussa V. F., Evdemon-Hogan M., Mottram P., Wei S., David O., Curiel T. J., Zou W., Bone marrow is a reservoir for CD4 + CD25 + regulatory T cells that traffic through CXCL12/CXCR4 signals Cancer Research 2004 64 22 8451 8455 (Pubitemid 39491786)
68. Righi E., Kashiwagi S., Yuan J., Santosuosso M., Leblanc P., Ingraham R., Forbes B., Edelblute B., Collette B., Xing D., Kowalski M., Mingari M. C., Vianello F., Birrer M., Orsulic S., Dranoff G., Poznansky M. C., CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer Cancer Research 2011 71 16 5522 5534
69. Bartlett J. M., Langdon S. P., Scott W. N., Love S. B., Miller E. P., Katsaros D., Smyth J. F., Miller W. R., Transforming growth factor- isoform expression in human ovarian tumours European Journal of Cancer 1997 33 14 2397 2403 (Pubitemid 28129184)
70. Cazac B. B., Roes J., TGF- receptor controls B cell responsiveness and induction of IgA in vivo Immunity 2000 13 4 443 451
71. Schlingensiepen K. H., Fischer-Blass B., Schmaus S., Ludwig S., Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors Recent Results in Cancer Research 2008 177 137 150
72. Melisi D., Ishiyama S., Sclabas G. M., Fleming J. B., Xia Q., Tortora G., Abbruzzese J. L., Chiao P. J., LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis Molecular Cancer Therapeutics 2008 7 4 829 840 (Pubitemid 351551036)
73. Wei S., Shreiner A. B., Takeshita N., Chen L., Zou W., Chang A. E., Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor Cancer Research 2008 68 13 5432 5438
74. Zou W., Chen L., Inhibitory B7-family molecules in the tumour microenvironment Nature Reviews Immunology 2008 8 6 467 477 (Pubitemid 351733418)
75. Curiel T. J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K. L., Daniel B., Zimmermann M. C., David O., Burow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R. D., Emilie D., Curiel D. T., Chen L., Zou W., Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity Nature Medicine 2003 9 5 562 567 (Pubitemid 36597102)
76. Hamanishi J., Mandai M., Iwasaki M., Okazaki T., Tanaka Y., Yamaguchi K., Higuchi T., Yagi H., Takakura K., Minato N., Honjo T., Fujii S., Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3360 3365 (Pubitemid 46364164)
77. Ke W., Kryczek I., Chen L., Zou W., Welling T. H., Kupffer cell suppression of CD8 + T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions Cancer Research 2009 69 20 8067 8075
78. Wang W., Lau R., Yu D., Zhu W., Korman A., Weber J., PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4 + CD25 Hi regulatory T cells International Immunology 2009 21 9 1065 1077
79. Francisco L. M., Salinas V. H., Brown K. E., Vanguri V. K., Freeman G. J., Kuchroo V. K., Sharpe A. H., PD-L1 regulates the development, maintenance, and function of induced regulatory T cells Journal of Experimental Medicine 2009 206 13 3015 3029
80. Kryczek I., Wei S., Zhu G., Myers L., Mottram P., Cheng P., Chen L., Coukos G., Zou W., Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma Cancer Research 2007 67 18 8900 8905 (Pubitemid 47437467)
81. Kryczek I., Zou L., Rodriguez P., Zhu G., Wei S., Mottram P., Brumlik M., Cheng P., Curiel T., Myers L., Lackner A., Alvarez X., Ochoa A., Chen L., Zou W., B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma Journal of Experimental Medicine 2006 203 4 871 881